NDAINJECTIONINJECTABLE
Approved
Jun 1987
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
2/8 — Basic
CIS-PYRO (technetium tc99m pyrophosphate) by PharmaIN is radiopharmaceutical activity [moa]. First approved in 1987.
Drug data last refreshed 8h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
CIS-PYRO is a technetium Tc-99m pyrophosphate radiopharmaceutical diagnostic agent administered by injection to visualize and assess cardiac and blood pool function. It works through radiopharmaceutical activity, binding to red blood cells and myocardial tissue to enable nuclear imaging. This agent has been a cornerstone of nuclear cardiology since its 1987 approval.
LOE Approaching
With LOE approaching and moderate competitive pressure (30%), the brand team is likely focused on portfolio defense and maximizing remaining exclusivity window, indicating a smaller, mature commercial organization.
Mechanism of Action
Radiopharmaceutical Activity
Pharmacologic Class:
Radioactive Diagnostic Agent
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on CIS-PYRO offers exposure to mature product lifecycle management, regulatory defense, and the specialized nuclear medicine space, but limited growth or innovation opportunities. Career development on this product is best suited for professionals focused on operational excellence and competitive positioning in a declining market segment.
Brand Manager
Worked on CIS-PYRO at PharmaIN? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.